Arno Therapeutics, Inc. (ARNI)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
-0.0002 (-99.50%)
At close: Jan 30, 2026
Arno Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | 2010 - 2006 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '16 Sep 30, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 | 2010 - 2006 |
| Cash & Equivalents | 2.12 | 0.07 | 7.95 | 26.77 | 10.94 | 6.68 | Upgrade
|
| Cash & Short-Term Investments | 2.12 | 0.07 | 7.95 | 26.77 | 10.94 | 6.68 | Upgrade
|
| Cash Growth | 1623.08% | -99.16% | -70.31% | 144.66% | 63.87% | -50.63% | Upgrade
|
| Prepaid Expenses | 0.2 | 0.26 | 0.26 | 0.09 | 0.2 | 0.3 | Upgrade
|
| Total Current Assets | 2.33 | 0.33 | 8.21 | 26.86 | 11.15 | 6.98 | Upgrade
|
| Property, Plant & Equipment | 0.02 | 0.02 | 0.03 | 0.01 | 0.02 | 0.04 | Upgrade
|
| Long-Term Deferred Charges | - | - | - | - | 1.71 | - | Upgrade
|
| Other Long-Term Assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Total Assets | 2.36 | 0.36 | 8.25 | 26.88 | 12.89 | 7.02 | Upgrade
|
| Accounts Payable | 1.07 | 1.01 | 0.74 | 2.94 | 1.55 | 0.68 | Upgrade
|
| Accrued Expenses | 0.46 | 1.12 | 1.41 | 0.95 | 1.09 | 1.27 | Upgrade
|
| Short-Term Debt | - | 2.09 | - | - | - | - | Upgrade
|
| Current Portion of Leases | 0 | 0 | 0 | - | - | - | Upgrade
|
| Other Current Liabilities | 0 | 0 | 0 | 0.01 | 0.61 | 0.01 | Upgrade
|
| Total Current Liabilities | 1.53 | 4.23 | 2.16 | 3.9 | 3.25 | 1.96 | Upgrade
|
| Long-Term Debt | - | - | - | - | 0.49 | - | Upgrade
|
| Long-Term Leases | 0 | 0 | 0.01 | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 6.54 | 4.75 | 3.12 | 35.5 | 20.52 | - | Upgrade
|
| Total Liabilities | 8.07 | 8.99 | 5.29 | 39.4 | 24.26 | 1.96 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 97.12 | 84.67 | 81.19 | 76.67 | 37.63 | 36.87 | Upgrade
|
| Retained Earnings | -103 | -93.29 | -81.79 | -89.56 | -49.9 | -35.51 | Upgrade
|
| Total Common Equity | -5.71 | -8.62 | -0.59 | -12.88 | -12.27 | 1.36 | Upgrade
|
| Shareholders' Equity | -5.71 | -8.62 | 2.96 | -12.52 | -11.37 | 5.06 | Upgrade
|
| Total Liabilities & Equity | 2.36 | 0.36 | 8.25 | 26.88 | 12.89 | 7.02 | Upgrade
|
| Total Debt | 0.01 | 2.1 | 0.01 | - | 0.49 | - | Upgrade
|
| Net Cash (Debt) | 2.12 | -2.03 | 7.94 | 26.77 | 10.45 | 6.68 | Upgrade
|
| Net Cash Growth | 1751.10% | - | -70.36% | 156.15% | 56.51% | -50.63% | Upgrade
|
| Net Cash Per Share | 0.06 | -0.10 | 0.32 | 3.56 | 2.30 | 1.55 | Upgrade
|
| Filing Date Shares Outstanding | 49.35 | 41.56 | 20.41 | 20.37 | 4.55 | 4.54 | Upgrade
|
| Total Common Shares Outstanding | 47.85 | 20.41 | 20.41 | 20.37 | 4.55 | 4.54 | Upgrade
|
| Working Capital | 0.8 | -3.9 | 6.05 | 22.96 | 7.9 | 5.01 | Upgrade
|
| Book Value Per Share | -0.12 | -0.42 | -0.03 | -0.63 | -2.70 | 0.30 | Upgrade
|
| Tangible Book Value | -5.71 | -8.62 | -0.59 | -12.88 | -12.27 | 1.36 | Upgrade
|
| Tangible Book Value Per Share | -0.12 | -0.42 | -0.03 | -0.63 | -2.70 | 0.30 | Upgrade
|
| Machinery | - | 0.09 | 0.09 | 0.07 | 0.07 | 0.07 | Upgrade
|
| Leasehold Improvements | - | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.